Glenmede Trust CO Na Compugen LTD Transaction History
Glenmede Trust CO Na
- $20.6 Billion
- Q3 2024
A detailed history of Glenmede Trust CO Na transactions in Compugen LTD stock. As of the latest transaction made, Glenmede Trust CO Na holds 27,500 shares of CGEN stock, worth $63,525. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,500
Previous 27,500
-0.0%
Holding current value
$63,525
Previous $46,000
6.52%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CGEN
# of Institutions
75Shares Held
12MCall Options Held
79.2KPut Options Held
12.7K-
Silverarc Capital Management, LLC1.5MShares$3.47 Million0.68% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.29MShares$2.97 Million0.0% of portfolio
-
Taylor Frigon Capital Management LLC1.2MShares$2.78 Million1.09% of portfolio
-
Macquarie Group LTD Australia, C31.02MShares$2.36 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD990KShares$2.29 Million0.06% of portfolio
About COMPUGEN LTD
- Ticker CGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,600
- Market Cap $200M
- Description
- Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...